Search results for "34"
showing 10 items of 1830 documents
VALUTAZIONE DELLA COMPLIANCE E DELLA PERSISTENZA NELLA TERAPIA DELL’OSTEOPOROSI CON ALENDRONATO: NOSTRA ESPERIENZA
2017
Studio RIFRA: il rischio fratturativo in Italia
2017
L'osteoporosi è un disordine scheletrico cronico-evolutivo, caratferizzato dalla perdita dell'equilibrio del metabolismo osseo con conseguente degenerazione quantitativa e qualitativa che compromette la resistenza dell'osso e predispone ad un aumentato rischio di fratture. Colpisce soprattutto il sesso femminile,conunaprevalenza del33%nelrange tra60eT0aacheaumentaconl'avanzaredell'età. Può rimanere clinicamente silente e successivamente manifestarsi con fratture (vertebrali 100.000 casi/anno, di polso 85.000 casi/anno e femorali 80.000 casi/anno). Le fratture da fragilità comportano gravi conse gseîze, sia a livello clinico individuale che sociale ed economico; rappresenrano pertanto una fo…
Vertebral fracture, function and cognitive status in osteoporotic hip fractured women: The FOCUS study
2017
Osteoporosis is characterizated by low bone mass and microarchitectural modifications of bone tissue with a consequent increase in fragility fracture.
LA PALMITOILETANOLAMIDE NEL DOLORE RADICOLARE DA ERNIA DISCALE LOMBARE IN SINERGIA AL TRATTAMENTO RIABILITATIVO
2017
PIEDE PIATTO OPERATO NELL'ETA' EVOLUTIVA:STRATEGIE RIABILITATIVE
2008
PROGRAMMA RIABILITATIVO DEL PIEDE PIATTO OPERATO NELL'ETA' EVOLUTIVA
2008
Il ruolo della riabilitazione nei pazienti con morbo di Parkinson trattati con DBS
2015
Treatment adherence and QoL with intermittent PTH therapy: Results from a multicentre Italian study after 6 months
2011
This ongoing multicentre study was carried out to investigate the adherence to intermittent parathyroid hormone treatment and the effect on QoL in a typical Italian population eligible for drug reimbursement (i.e. a new vertebral or hip fracture following at least one year of anti-resorptive therapy or three severe vertebral fractures or two severe and one femur fracture). 204 female patients (mean age: 72.6±8.3) were enrolled between March 2008 and April 2009. These patients were treated with PTH (PTH 1–34 or PTH 1–84) according to Italian legislation. Here, we report the results obtained at month 6.
Chronic pain treatment through virtual reality
2017
Chronic pain is a notable issue of public healthcare, causing enormous direct and indirect costs, and a reduction of the quality of life in the affected patients. In this study, we have used Virtual Reality (VR) as a method to reduce stress, anxiety and pain in patients affected by chronic pain. We examined two cohorts of patients: an experimental group and a control group. The patients in the experimental group were administered eight VR sessions, each of those lasted thirty minutes, while the control group had a standard therapy. The results are encouraging: they demonstrate the efficacy of VR treatment and the safety of the method.